Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ISRG Intuitive Surgical	$519.81 +2.2%	$561.24	$364.17 ▼ $616.00	$185.15B	1.43	1.46 million shs	2.53 million shs
MDT Medtronic	$88.50 -1.8%	$90.90	$75.96 ▼ $96.25	$113.51B	0.8	6.11 million shs	8.82 million shs
PRCT PROCEPT BioRobotics	$62.53 +2.7%	$66.71	$45.56 ▼ $103.81	$3.43B	1.05	729,131 shs	1.36 million shs
ZBH Zimmer Biomet	$110.50 -0.7%	$106.98	$97.69 ▼ $133.90	$22.00B	1.04	1.50 million shs	1.30 million shs

2025 Gold Forecast: A Perfect Storm for Demand

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ISRG Intuitive Surgical	+3.27%	+4.05%	-14.06%	-5.30%	+29.06%
MDT Medtronic	-0.23%	-3.36%	+0.24%	+10.57%	+8.52%
PRCT PROCEPT BioRobotics	+4.82%	+3.17%	-2.17%	-27.26%	+27.75%
ZBH Zimmer Biomet	+0.47%	-0.48%	+6.12%	+3.74%	-12.49%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ISRG Intuitive Surgical	4.5587 of 5 stars	3.3	3.0	0.0	4.0	2.9	2.5	1.9
MDT Medtronic	4.2918 of 5 stars	2.2	3.0	3.3	4.0	3.4	2.5	0.6
PRCT PROCEPT BioRobotics	3.0669 of 5 stars	3.4	3.0	0.0	0.0	2.6	3.3	0.6
ZBH Zimmer Biomet	4.6249 of 5 stars	3.2	4.0	1.7	3.7	3.0	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ISRG Intuitive Surgical	2.67	Moderate Buy	$611.86	17.71% Upside
MDT Medtronic	2.44	Hold	$96.07	8.56% Upside
PRCT PROCEPT BioRobotics	2.86	Moderate Buy	$94.29	50.78% Upside
ZBH Zimmer Biomet	2.32	Hold	$124.15	12.35% Upside

Current Analyst Ratings Breakdown

Latest PRCT, ISRG, MDT, and ZBH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/18/2025	ISRG Intuitive Surgical	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$707.00 ➝ $600.00
3/17/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/17/2025	ISRG Intuitive Surgical	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$666.00 ➝ $605.00
3/4/2025	MDT Medtronic	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$92.00 ➝ $107.00
2/26/2025	PRCT PROCEPT BioRobotics	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$105.00 ➝ $95.00
2/26/2025	PRCT PROCEPT BioRobotics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$105.00 ➝ $90.00
2/19/2025	MDT Medtronic	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$105.00 ➝ $105.00
2/19/2025	MDT Medtronic	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$85.00 ➝ $95.00
2/19/2025	MDT Medtronic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/19/2025	MDT Medtronic	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$90.00 ➝ $91.00
2/12/2025	MDT Medtronic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 3/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ISRG Intuitive Surgical	$8.35B	22.17	$6.85 per share	75.93	$46.41 per share	11.20
MDT Medtronic	$33.20B	3.42	$7.25 per share	12.21	$38.69 per share	2.29
PRCT PROCEPT BioRobotics	$224.50M	15.27	N/A	N/A	$5.56 per share	11.25
ZBH Zimmer Biomet	$7.68B	2.86	$14.08 per share	7.85	$62.67 per share	1.76

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ISRG Intuitive Surgical	$2.32B	$6.41	81.09	68.13	5.85	27.81%	14.55%	12.88%	4/17/2025 (Estimated)
MDT Medtronic	$3.68B	$3.29	26.90	15.18	2.22	12.83%	14.07%	7.70%	5/22/2025 (Estimated)
PRCT PROCEPT BioRobotics	-$105.90M	-$1.76	N/A	N/A	N/A	-50.07%	-38.57%	-26.06%	5/7/2025 (Estimated)
ZBH Zimmer Biomet	$903.70M	$4.45	24.83	12.46	1.95	11.77%	12.99%	7.58%	5/1/2025 (Estimated)

Latest PRCT, ISRG, MDT, and ZBH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/17/2025	N/A	ISRG Intuitive Surgical	$1.71	N/A	N/A	N/A	$2.19 billion	N/A
2/25/2025	Q4 2024	PRCT PROCEPT BioRobotics	-$0.34	-$0.35	-$0.01	-$0.35	$66.79 million	$68.24 million
2/18/2025	Q3 2025	MDT Medtronic	$1.36	$1.39	+$0.03	$1.01	$8.33 billion	$8.29 billion
2/6/2025	Q4 24	ZBH Zimmer Biomet	$2.30	$2.31	+$0.01	$1.20	$2.01 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
MDT Medtronic	$2.80	3.16%	+4.14%	85.11%	48 Years
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	0.87%	N/A	21.57%	N/A

Latest PRCT, ISRG, MDT, and ZBH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/26/2025	ZBH Zimmer Biomet	quarterly	$0.24	0.89%	3/31/2025	3/31/2025	4/30/2025
3/6/2025	MDT Medtronic	quarterly	$0.70	3%	3/28/2025	3/28/2025	4/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ISRG Intuitive Surgical	N/A	4.07	3.22
MDT Medtronic	0.48	1.90	1.39
PRCT PROCEPT BioRobotics	0.21	6.02	5.07
ZBH Zimmer Biomet	0.43	1.91	0.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ISRG Intuitive Surgical	83.64%
MDT Medtronic	82.06%
PRCT PROCEPT BioRobotics	89.46%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
ISRG Intuitive Surgical	0.90%
MDT Medtronic	0.20%
PRCT PROCEPT BioRobotics	17.40%
ZBH Zimmer Biomet	0.95%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ISRG Intuitive Surgical	12,100	356.18 million	352.97 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
PRCT PROCEPT BioRobotics	430	54.82 million	43.10 million	Optionable
ZBH Zimmer Biomet	18,000	199.06 million	197.18 million	Optionable

PRCT, ISRG, MDT, and ZBH Headlines

Recent News About These Companies

771,063 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Sound Shore Management Inc. CT

March 25 at 6:49 AM | marketbeat.com

111,244 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by KLP Kapitalforvaltning AS

March 25 at 4:48 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Mizuho Securities USA LLC

March 25 at 4:38 AM | marketbeat.com

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

March 24 at 9:48 AM | msn.com

Is Zimmer Biomet Stock Outperforming the S&P 500?

March 24 at 9:48 AM | msn.com

Crowley Wealth Management Inc. Makes New $723,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 24 at 7:17 AM | marketbeat.com

Sei Investments Co. Has $75.57 Million Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 24 at 5:34 AM | marketbeat.com

Sciencast Management LP Purchases 2,391 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 24 at 5:17 AM | marketbeat.com

Virtu Financial LLC Sells 5,337 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 24 at 4:59 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Teacher Retirement System of Texas

March 24 at 4:41 AM | marketbeat.com

American Century Companies Inc. Cuts Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 23 at 6:32 AM | marketbeat.com

Northwest & Ethical Investments L.P. Purchases New Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 23 at 5:14 AM | marketbeat.com

Sector Gamma AS Has $14.55 Million Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 22 at 6:51 AM | marketbeat.com

Vinva Investment Management Ltd Purchases Shares of 10,057 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 22 at 5:02 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Average Rating of "Hold" from Analysts

March 22 at 4:27 AM | marketbeat.com

Cibc World Markets Corp Has $3.34 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 22 at 4:18 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Corient Private Wealth LLC

March 22 at 4:10 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Boosted by Natixis Advisors LLC

March 22 at 4:01 AM | marketbeat.com

Should You Consider Retaining ZBH Stock in Your Portfolio Now?

March 21, 2025 | zacks.com

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

March 21, 2025 | msn.com

5,300 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Tocqueville Asset Management L.P.

March 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, ISRG, MDT, and ZBH Company Descriptions

Intuitive Surgical NASDAQ:ISRG

$519.81 +11.23 (+2.21%)

Closing price 04:00 PM Eastern

Extended Trading

$521.90 +2.10 (+0.40%)

As of 07:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Medtronic NYSE:MDT

$88.50 -1.63 (-1.81%)

Closing price 03:58 PM Eastern

Extended Trading

$88.40 -0.11 (-0.12%)

As of 07:55 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

PROCEPT BioRobotics NASDAQ:PRCT

$62.53 +1.63 (+2.68%)

Closing price 04:00 PM Eastern

Extended Trading

$62.60 +0.06 (+0.10%)

As of 07:38 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Zimmer Biomet NYSE:ZBH

$110.50 -0.74 (-0.67%)

Closing price 03:58 PM Eastern

Extended Trading

$110.48 -0.03 (-0.02%)

As of 04:47 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time